Tofacitinib Citrate is an oral, small-molecule inhibitor that target-blocks the Janus kinase (JAK) pathway. By disrupting the signaling network of inflammatory cytokines, it effectively dampens the overactive immune responses responsible for chronic autoimmune conditions.
Reviews
There are no reviews yet.